Hospital Universitario Fundacion Jimenez Diaz — Clinical Trial Site

775 Registered trials

312 Currently recruiting

Organisation

Hospital Universitario Fundacion Jimenez Diaz

Location

Madrid, Spain

Identifier

ORG-100028994

Address

Avenida De Los Reyes Catolicos 2, 28040, Spain

Departments

-
#03402 :Oncología
#11101:Neurology
#1703: Oncologia
#2006:Oncology
#2243; Nefrología
#2309:servicio de neurología
#2410: Neurología
#2504: Servicio de oncología
#2609: Urology
#3101:Oncología médica
#3277:Urologia
#4205:Servicio de Cardiología
#6001: Servicio Oncología
#6002:Oncología
#7002:Medical Oncology
#7005: Oncología Médica
#7017:Dermatología
034027: Oncología
1311: Hematología y Hemoterapia
1603 :Oncología
172415: Hematología
3008:Traumatología
3108: neurologia
3122: medicina interna
3312: Oncología
3604; Oncología Médica
4205: Cardiólogos
5512: Neumología
600 : Oncología
6004:Oncologia Médica
7001: Hematología y Hemoterapia
7002: Oncología
7003: Ensayos clínicos Hematología
7004: Phase I Clinical Trials Unit
7005: Oncología Medica
7012:Oncología Médica
7117:Oncología
7208: Neurology
724003:Oncología
9001: Hematología
Alergology
Allergy
Allergy Department
Calvo
Cardiología
Cardiology
Cardiology Department
Cirugía
Clinical Hematology
Coloproctología
Departamento de Ginecología
Department of Medical Oncology, Oncohealth Institute
department of Nephrology
Department of Oncology
Department of Ophthalmology, Fundación Jiménez Díaz University Hospita
Department of surgery
Dermatologia
Dermatology
Digestive
Digestive. Gastroenterology. Endoscopy.
Early Phase 1 UNIT
Early Phase Clinical Trial Unit
Endocrinology
Enfermedades Infecciosas
ES30010: Hematología y Hemoterapia
ESP001: Oncología
Fundacion Jimenez Diaz( #1)
Gastroenterologist
Gastroenterology
Gastroenterology and Hepatology
General and Digestive Surgery.
Ginecología
Gynecology
Gynecology Oncology
Haematology
Haematology and Hemotherapy
Haematology Service
Head of Immunization Department
Hematolgy
Hematología
Hematology
Hematology and Hemotherapy
Hematology and Hemotherapy Service
Hematology Department
hematology service
Hematololgy
Hospital Universitario Fundación Jiménez Díaz
Infectious department
Infectious disease
Infectious Diseases
Intensive Care medicine
Internal Medicine
Internal Medicine - Diabetioloy
Internal Medicine department-Infectious diseases
Internal Medicine Service
Lymphoma department
Lymphoma Unit
Medica Oncology
Medical Oncology
Medical Oncology Department
Medical Oncology Service
Medicina Nuclear
N/A
NA
Nefrologia
Nefrología e Hipertensión
Nefrology
Nephorogy Service
Nephrology
Nephrology and Hypertension Department
Nephrology Service
Neprology
NEUMOLOGÍA
Neumology
Neurología
Neurology
Neurology Department
Not applicable
Obstetrics and Gynecology
Oftalmologia
Onccology
Oncolgy
Oncologia
Oncología Médica
Oncología Radioterápica
Oncología, 504
Oncología, Unidad de Fase 1
Oncology
Oncology – Phase 1 Clinical Trials
Oncology & Hematology
Oncology Department
Oncology Medicine
Oncology Service
Oncology, Start Madrid-FJD, Hospital Fundacion Jimenez Diaz
Ophthalmology
Orthopaedic Surgery and Traumatology
Otorhinolaryngolog Service
Otorhinolaryngology
Pediatric Endocrinology
Pediatric Gastroenterologist
Pediatrics department
Peritoneal Oncology Surgery
Phase I Clinical Trials
Phase I Clinical Trials Unit
Pneumology
Preventive Medicine
Preventive medicine and public health service
Pulmonology
Research Facility
Respiratory medicine
Reumatología
Rheumatology
Servicio de Endocrinología y Nutrición
Servicio de Enfermedades Infecciosas
Servicio de Hamatologia
Servicio de Hematología
Servicio de Infecciosas
Servicio de Medicina Interna
Servicio de Medicina Preventiva
Servicio de Nefrología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Servicio de Neumología
Servicio de Neurologia
Servicio de Oftalmologia
Servicio de Oncologia
Servicio de Oncología médica
Servicio de Otorrinolaringología
Servicio de Reumatología
Servicio de Urología
Servicio Enfermedades Infecciosas
Servicio oftalmologia
START
START - Madrid -FJD
START Madrid
START Madrid - FJD
Start Madrid - Phase I Unit
START Madrid FJD.Phase 1 Trials
START Madrid-FJD
START Madrid-FJD, Hospital Fundacion Jimenez Diaz
START Madrid-FJD, Phase I Clinical Trials Unit
Start Madrid-Hematology
Start Unit
Start_Oncology
START-FJD, Early Phase Clinical Trials Unit
Surgery and New Therapies Laboratory
Thoracic Oncology
Unidad de Enfermedades Infecciosas
Unidad de Ensayos Clínicos Fase I
Unidad de ensayos clínicos, fase 1
Unidad de Ensayos Fase I
Unidad Ensayos Fase I - Oncology
Unidad START-Madrid FJD
Urologia
Urology

Clinical trials at this site (775)

Search interface

A clinical trial investigating the safety, tolerability, and therapeutic effects of BNT113 in combination with pembrolizumab versus pembroli… Recruiting

2024-512671-12-00 Unresectable head and neck squamous cell carcinoma, met 10 2021-03-05
A First-in-Human Study to Evaluate the Safety and Anti-cancer Activity of the product FS222, which is an Antibody medication, in Subjects wi… Recruiting

2024-514010-12-00 Advanced Malignancies 1 2020-12-03
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other… Recruiting

2024-510783-23-00 Fallopian Tube Cancer 7 2020-10-29
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to… Recruiting

2023-509847-29-00 Advanced solid tumors 7 2020-04-09
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-00… Recruiting

2024-512606-25-00 Advanced Solid Tumors 7 2019-12-20
Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma Recruiting

2023-509179-18-00 Small Cell Lung Cancer (SCLC) 1 2019-08-13
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Advanced tumors 5 2018-08-24
Study to allow access to dabrafenib and/or trametinib for subjects that are benefiting from dabrafenib and/or trametinib treatment in a Nova… Recruiting

2023-509318-13-00 Multiple indications 6 2018-01-15
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting

2024-516078-31-00 Recurrent and Primary Refractory Ewing Sarcoma 10 2015-05-05
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
A study of S095035 as a single agent and in combination in adult participants with advanced or metastatic solid tumors with deletion of MTAP Ended

2025-521249-25-00 MTAP-deleted advanced or metastatic solid tumors 7 2025-10-30
Ribociclib in combination with endocrine therapy in patients with “estrogen receptor-positive and HER2-negative” breast cancer with high ris… Ended

2023-508827-10-00 Patients with primary operable stage II, grade 2 or 3, 4 2025-10-13
Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC) Ended

2025-521681-10-00 Lung Cancer 4 2025-10-02
An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachmen… Ended

2025-520629-19-00 HIV Infections 3 2025-10-01
A Study to Compare Different Doses of RO7795081 with a Placebo or Semaglutide in People with Type 2 Diabetes Ended

2024-520322-11-00 Type 2 Diabetes Mellitus (T2D) 4 2025-09-29
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Compared to Oral Lenvatinib Capsul… Ended

2024-518012-39-00 Squamous-Cell Non-Small Cell Lung Cancer 1 2025-09-22
A trial to learn how safe baxdrostat is and how well it works in adults with primary aldosteronism Ended

2025-520740-16-00 Primary Aldosteronism defined by excess aldosterone sec 5 2025-09-19
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD) Ended

2025-520488-42-00 Moderate-to-Severe Chronic Obstructive Pulmonary Diseas 4 2025-09-17
A study on the safety, and immunogenicity of a UTI vaccine in adults 18 through 64 years of age and clinical efficacy in females 18 through … Ended

2024-519319-32-00 Urinary Tract Infections 7 2025-08-27
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31
A Study of ABBV-CLS-628 in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease Ended

2024-517143-31-00 Autosomal Dominant Polycystic Kidney Disease 4 2025-07-18
A PHASE 1B, OPEN-LABEL, DOSE ESCALATION WITH AN EXPANSION TRIAL OF A IN COMBINATION WITH B OR A PLUS STANDARD OF CARE IN PATIENTS WITH XXX C… Ended

2025-521582-27-00 XXX CANCER ELIGIBLE FOR SECOND LINE TREATMENT 3 2025-07-03
Phase 1b/2 Study of Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC) Ended

2024-517817-34-00 Gastric Cancer 9 2025-06-18